Find a Clinical Trial

Filter

Showing 141 - 150 out of 196

COVID-19 Survivors Registry

National COVID-19 Survivors Registry

COVID-19

All genders

18+

Recruiting now

Department of Medicine, Division of Geographic Medicine + Infectious Diseases

Tufts Medical Center

Learn more

NASA

Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

Dry eyes

All genders

21+

Recruiting now

Department of Ophthalmology

Tufts Medical Center

Learn more

IMPACT/SWAGGER

Non Exudative Age-Related Macular Degeneration Imaged with Swept Source Optical Coherence Tomography

Macular degeneration

All genders

50+

Recruiting now

Department of Ophthalmology

Tufts Medical Center

Learn more

Non- Invasive, Label-free Detection of Cervical Pre-Cancers In vivo

Non-Invasive, Label-free Detection of Cervical Pre-Cancers In vivo

Cervical cancer

All genders

18-100

Recruiting now

Department of Obstetrics + Gynecology

Tufts Medical Center

Learn more

Functional Imaging for Ocular Blood Flow with OCTA

Novel Functional Imaging for Ocular blood flow with Optical Coherence Tomography Angiography

Macular degeneration, Retinal disorders

All genders

18+

Recruiting now

Department of Ophthalmology

Tufts Medical Center

Learn more

OCS Heart Perfusion Registry

OCS Heart Perfusion Post- Approval Registry

Heart transplantation

All genders

18+

Recruiting now

CardioVascular Center

Tufts Medical Center

Learn more

Decartes-08 for Myasthenia Gravis

OGOUS T-CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
DIRECTED TO B-CELL MATURATION ANTIGEN (BCMA) IN PATIENTS
WITH GENERALIZED MYASTHENIA GRAVIS (MG)

Myasthenia gravis

All genders

18+

Recruiting now

Department of Neurology

Tufts Medical Center

Learn more

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Breast cancer

All genders

18+

Recruiting now

Department of Medicine, Division of Hematology/Oncology, Cancer Center

Tufts Medical Center

Learn more

SOS

Orthopaedic Sports Medicine, Arthoscopy, and Related Surgery Registry Using the Web-Based Surgical Outcomes System

Orthopaedic surgery

All genders

12+

Recruiting now

Department of Orthopaedic Surgery + Rehabilitation Medicine

Tufts Medical Center

Learn more

PBCAR0191

Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate Safety and Clinical Activity of PBCAR0191 in Subjects With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

All genders

18+

Recruiting now

Department of Medicine, Division of Hematology/Oncology, Cancer Center

Tufts Medical Center

Learn more

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

National COVID-19 Survivors Registry

Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

Non Exudative Age-Related Macular Degeneration Imaged with Swept Source Optical Coherence Tomography

Non-Invasive, Label-free Detection of Cervical Pre-Cancers In vivo

Novel Functional Imaging for Ocular blood flow with Optical Coherence Tomography Angiography

OCS Heart Perfusion Post- Approval Registry

OGOUS T-CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
DIRECTED TO B-CELL MATURATION ANTIGEN (BCMA) IN PATIENTS
WITH GENERALIZED MYASTHENIA GRAVIS (MG)

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Orthopaedic Sports Medicine, Arthoscopy, and Related Surgery Registry Using the Web-Based Surgical Outcomes System

Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate Safety and Clinical Activity of PBCAR0191 in Subjects With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)